- Fee assured
- Verified this account
This healthcare professional let us know that they are currently:
- Accepting new patients
- Available for:
- Phone consultations
- Video consultations
Last updated: 15 Apr 2020
- Paediatric respiratory medicine
Dr Nwokoro is primarily interested in the health and wellbeing of children and their families and will not address a clinical problem without consideration of the wider medical, social and emotional context. Alongside a breadth of general paediatric experience he has specific expertise in all manner of children's respiratory disease.
Known as “Dr Chin” to his patients he is GMC-certified in paediatrics and paediatric respiratory medicine. After medical school in Cambridge he trained at Great Ormond Street, St Mary’s, The Royal London and back to Cambridge before completing his doctoral thesis at Barts and the London School of Medicine.
A competent and sympathetic general paediatrician, he is head of children’s asthma and chronic lung disease at Barts Health NHS Trust and leads the NEL STP community asthma improvement programme.
An Honorary Clinical Senior Lecturer at Queen Mary University of London, he teaches undergraduate medical students and supervises BSc programmes. He has taught in Sudan on behalf of the RCPCH and the Egyptian and Sudanese Medical Associations. He is joint course director of the ‘Lung in Childhood’ London Paediatric Respiratory Medicine training programme and also teaches on general paediatric courses at Ealing, Whitechapel, and the Royal College of Paediatrics and Child Health.
He is happy to assess and treat all manner of paediatric concerns, with additional authority in diseases of the respiratory tract, and is happy to provide medicolegal advice in this context if required.
Dr Nwokoro was born in Leeds, moving to London aged 9. He studied at Haberdashers’ Aske’s school in Elstree before reading Medicine (also sprint hurdling and singing in a funk band) in Cambridge. He is settled in Hertfordshire with his wife and two young children and enjoys road cycling, skiing, writing and medicine. He is involved in campaign efforts to reduce air pollution around schools and elsewhere.
An accomplished clinical triallist, in 2017 Dr Nwokoro submitted his doctoral thesis entitled: “the role of arachidonic acid 5-lipoxygenase promoter polymorphism in response to montelukast in preschool wheezing children”, for which he was awarded the higher degree of Doctor of Medicine in 2018. He has published research in journals including The Lancet Respiratory Medicine, The British Medical Journal, The European Respiratory Journal, Archives of Disease in Childhood, Thorax and Paediatric Respiratory Reviews on topics such as preschool wheeze, air pollution and lung health, cystic fibrosis and eicosanoid biology and has spoken at national and international conferences including the John Price Respiratory Conference, the Royal College of Paediatrics and Child Health Spring Meeting, the European Respiratory Society Summer Meeting and the American Thoracic Society Conference.
Areas of interest
Children from birth to 16 in full time education
childhood asthma and wheezing disorders;
frequent respiratory infections;
snoring and sleep-disordered breathing;
extra-oesophageal reflux disease;
allergy and hay fever;
noisy breathing and laryngomalacia;
paediatric respiratory medicolegal work;
allergy; general paediatric problems
- NHS Practice: https://bartshealth.nhs.uk/find-a-consultant/?letter=N&consultant=966
- Personal Website - The Child Chest Clinic: http://www.childchestclinic.com
- The WAIT Study - primary paper: http://www.thelancet.com/journals/lanres/article/PIIS2213-2600(14)70186-9/abstract
Current NHS consultant posts held
I am a Consultant in Paediatric Respiratory Medicine at The Royal London Children's Hospital, Barts Health NHS Trust, serving as Clinical Lead for asthma, wheezing disease and chronic lung disease of prematurity, and sharing care for all other respiratory patients.
I am also an Honorary Clinical Senior Lecturer at The Blizard Institute, Queen Mary University of London where I teach medical students and conduct clinical research.
An accomplished clinical triallist, Dr Nwokoro has recently submitted his doctoral thesis entitled: “the role of arachidonic acid 5-lipoxygenase promoter polymorphism in response to montelukast in preschool wheezing children”. He has published research in journals including The Lancet Respiratory Medicine, The British Medical Journal, The European Respiratory Journal, Archives of Disease in Childhood, Thorax and Paediatric Respiratory Reviews on topics such as preschool wheeze, air pollution and lung health, cystic fibrosis and eicosanoid biology and has spoken at national and international conferences including the John Price Respiratory Conference, the Royal College of Paediatrics and Child Health Spring Meeting, the European Respiratory Society Summer Meeting and the American Thoracic Society Conference.
Dr Nwokoro was born in Leeds, moving to London aged 9. He studied at Haberdashers’ Aske’s school in Elstree before reading Medicine (also sprint hurdling and singing in a funk band) in Cambridge. He is settled in Hertfordshire with his wife and two young children and enjoys road cycling, skiing, singing, creative writing and paediatrics. He is involved in campaign efforts to reduce air pollution around schools and elsewhere.
Dr Nwokoro has received research grant funding from the Barts and the London Charity and the Darzi Foundation, and travel grant awards from the British Paediatric Respiratory Society, the British Lung Foundation and the American Thoracic Society. The Darzi funding includes £60,000 to support a Darzi Leadership fellow to improve local asthma standards in East London.
(Additional) Languages spoken
- French - Conversational
1) Davies P, Nwokoro C, Leigh M. Vaccinations against influenza and pneumococcus in children with diabetes: telephone questionnaire study. BMJ 2004; 328: 203.
2) Cycling to work in London and inhaled dose of black carbon. Nwokoro C, Ewin C, Harrison C, Ibrahim M, Dundas I, Dickson I, Mushtaq N, Grigg J. Eur Respir J 2012; 40: 1091–1097.
3) Letter in response to editorial. Alveolar macrophages carbon load: A marker of exposure? Nwokoro C, Brugha R, Grigg J. Eur Respir J 2013; 41: 763–766
4) Recruiting ethnic minority participants to a clinical trial: a qualitative study. MacNeill V, Nwokoro C, Griffiths C, Grigg J, Seale C. BMJ Open. 2013 Apr 8;3(4).
5) Upper Respiratory Tract Infections: Chapter in ERS Paediatric Hermes Handbook. Brugha C, Nwokoro C, Grigg J. 2013, European Respiratory Society. ISBN 9781849840385.
6) Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial. Nwokoro C et al. Lancet Respir Med. 2014 Oct;2(10):796-803.
7) Nwokoro CE. Highlights of the 28(th) North American Cystic Fibrosis Conference 2014. Paediatr Respir Rev. 2015 Oct;16 Suppl 1:12-4. doi:10.1016/j.prrv.2015.07.009. Epub 2015 Sep 26. Review.
8) Nwokoro C, et al.Parent-determined oral montelukast therapy for preschool wheeze with stratification for arachidonate 5-lipoxygenase (ALOX5) promoter genotype: a multicentre, randomised, placebo-controlled trial. Efficacy Mech Eval 2015;2(6)
9) Grigg J, Whitehouse A Pandya H, Turner S, Griffiths C J, Vulliamy T, Walton R, Price D, Sanak M, Holloway J W, Noimark L, Lesosky M, Brugha R, Koh L and Nwokoro C (2016) Urinary prostanoids in preschool wheeze European Respiratory Journal, 49, (2), p. 1601390
10) Griese M, Seidl E, Hengst M, et al. International management platform for children’s interstitial lung disease (chILD-EU). Thorax. Published Online First: 22 October 2017. doi: 10.1136/thoraxjnl-2017-210519
11) Edmondson C, Grime C, Prasad A, Cowlard J, Nwokoro C. et al. Cystic fibrosis newborn screening: outcome of infants with normal sweat tests. Archives of Disease in Childhood Published Online First: 07 November 2017. doi: 10.1136/archdischild-2017-313290
12) Nwokoro C, Grigg J. Preschool wheeze, genes and treatment. Paediatr Respir Rev. In press.
13) Gomez-Pastrana D, Nwokoro C et al.
[Real-world effectiveness of ivacaftor in children with cystic fibrosis and the
G551D mutation]. An Pediatr (Barc). 2018 Aug 6. pii: S1695-4033
Courses offered to GPs
Dr Nwokoro is happy to speak to GPs on a range of topics including: an approach to chronic cough, wheezing disease, reducing asthma deaths, respiratory conundrums, personalised medicine in paediatrics. He is also happy to speak to school groups on career options in medicine, healthy lifestyle, research and the like.
Outcomes (checked and approved by medical professional body)
Please click on this link if you would like to see information about this healthcare professional’s performance compared to their peers, as published by their medical professional body.https://www.iwantgreatcare.org/doctors/dr-chinedu-nwokoro
- Bachelor of Medicine University of Cambridge 2001
- Bachelor of Surgery University of Cambridge 2000
- Membership of the Royal College of Child Health RCPCH 2004
- Master of Arts University of Cambridge 2002
- Doctor of Medicine University of Cambridge 2018
Reference number 4766917
Professional bodies (positions held - last 3 yrs)
- Honorary Clinical Senior Lecturer in Paediatrics Queen Mary University of London 2013
- Course Director The Lung in Childhood Seminar Program 2018
Details of entry to specialist register
- Paediatrics, 2011
- Paediatric respiratory medicine, 2011
Affiliations / memberships
Member of the Royal College of Paediatrics and Child Health;
Member of the British Paediatric Respiratory Society
Member of the European Respiratory Society
- Elstree Outpatients Centre Beaufort HouseThe...
- 14:00 - 16:00
- 020 3594 2473
- One Hatfield Hospital 3 Hatfield Avenue...
- 10:00 - 12:00
- 020 3594 2473
- One Hatfield Hospital 3 Hatfield Avenue...
- 10:00 - 12:00
- 020 3594 2473
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.